Log in to save to my catalogue

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humor...

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_745636441

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types

About this item

Full title

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types

Publisher

Kidlington: Elsevier Ltd

Journal title

Vaccine, 2010-04, Vol.28 (19), p.3479-3487

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractBoth Human Papillomavirus (HPV) type 16/18 bivalent vaccine and type 16/18/6/11 quadrivalent vaccine have been proved to be safe and effective, and licensed for public use. However, these two vaccines do not quite match the distribution of HPV types in China, Southeast Asia and Latin America, where HPV 58 is highly prevalent. Here we produc...

Alternative Titles

Full title

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_745636441

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_745636441

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2010.02.057

How to access this item